Pfizer Tries to Outrun China Drug Policy With Rural Sales Push

(Bloomberg) -- Pfizer Inc. is pushing into rural China as a generic-drug purchasing program for major cities has hurt sales of the company’s aging blockbuster treatments for heart disease.

Bloomberg Quint

Add BloombergQuint App to Home screen.